Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology

SIMPLE SUMMARY: Triple-negative breast cancer (TNBC), the most aggressive and heterogenous type of cancer, lacks the expression of hormones like estrogen, progesterone, and human epidermal growth receptor-2, making chemotherapy the only treatment regimen against TNBC. It was further observed that ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudhuri, Aiswarya, Kumar, Dulla Naveen, Dehari, Deepa, Patil, Rohit, Singh, Sanjay, Kumar, Dinesh, Agrawal, Ashish Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177107/
https://www.ncbi.nlm.nih.gov/pubmed/37174125
http://dx.doi.org/10.3390/cancers15092661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177107/
https://www.ncbi.nlm.nih.gov/pubmed/37174125
http://dx.doi.org/10.3390/cancers15092661

Ejemplares similares